Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Intra-individual Cross-over Efficacy Evaluation of Dotarem®-Enhanced MRI Compared to Gadovist®/ Gadavist®-Enhanced MRI in the Diagnosis of Brain Tumors

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT02034708
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:36:20.426910+00:00
Published At
2016-10-25T00:00:00+00:00
Record Updated At
2016-12-30
Results Posted At
2016-10-25
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Primary Brain Tumor"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2016-12-30"
protocolSection.identificationModule.nctId
"NCT02034708"
protocolSection.identificationModule.officialTitle
"Intra-individual Cross-over Efficacy Evaluation of Dotarem\u00ae-Enhanced MRI Compared to Gadovist\u00ae/ Gadavist\u00ae-Enhanced MRI in the Diagnosis of Brain Tumors"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["PHASE4"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2016-10-25"

Study condition terms

  • Primary Brain Tumor (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.